BR0007729A - Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound - Google Patents

Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound

Info

Publication number
BR0007729A
BR0007729A BR0007729-1A BR0007729A BR0007729A BR 0007729 A BR0007729 A BR 0007729A BR 0007729 A BR0007729 A BR 0007729A BR 0007729 A BR0007729 A BR 0007729A
Authority
BR
Brazil
Prior art keywords
compound
therapy
pharmaceutical composition
methods
need
Prior art date
Application number
BR0007729-1A
Other languages
Portuguese (pt)
Inventor
Yang-I Lin
Panayota Bitha
Zhong Li
Gerardo Delacruz Francisco
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of BR0007729A publication Critical patent/BR0007729A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, MéTODOSDE CONTROLE DE INFECçõES BACTERIANAS EM UMHOSPEDEIRO EM NECESSIDADE DE TAL TERAPIA, E DEPREPARO DE UM COMPOSTO". São fornecidos compostostendo as fórmulas (I) e (II) em que n é O ou 1 e, quando n = 1, R éum anel heterocíclico de 5 ou 6 membros, hidróxi, halogênio, oxo,carbamoíla, alcóxi ou amino dissubstituído, quando n = 0, R é umgrupo éster, ciano ou amida; X é CH ou NH; ~ 3~é ciano, metóxiou acetamido; R~ 1~, é hidrogênio, alquila, uma carga negativa,um cátion selecionado do grupo consistindo de sódio, potássio etetraalquilamónio e aciloxialquila, ou alcoxicarboniloxialquila; e R~2~ é hidrogênio, acila, carbamoíla, silila trissubstituída ou umresíduo de aminoácido; ou seus sais farmaceuticamenteaceitáveis."COMPOUND, PHARMACEUTICAL COMPOSITION, AND, METHODS OF CONTROL OF BACTERIAL INFECTIONS IN A HOUSEHOLDER IN NEED OF SUCH THERAPY, AND DEPREPARATION OF A COMPOUND". They are provided comprising the formulas (I) and (II) in which n is O or 1 and, when n = 1, R is a 5- or 6-membered heterocyclic ring, hydroxy, halogen, oxo, carbamoyl, alkoxy or disubstituted amino, when n = 0, R is an ester, cyano or amide group; X is CH or NH; ~ 3 ~ is cyano, methoxy or acetamido; R ~ 1 ~, is hydrogen, alkyl, a negative charge, a cation selected from the group consisting of sodium, potassium etetraalkylammonium and acyloxyalkyl, or alkoxycarbonyloxyalkyl; and R ~ 2 ~ is hydrogen, acyl, carbamoyl, trisubstituted silyl or an amino acid residue; or their pharmaceutically acceptable salts.

BR0007729-1A 1999-01-26 2000-01-26 Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound BR0007729A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23772699A 1999-01-26 1999-01-26
PCT/US2000/001630 WO2000043399A1 (en) 1999-01-26 2000-01-26 3,6-disubstituted penam sulfone derivatives as antibacterials

Publications (1)

Publication Number Publication Date
BR0007729A true BR0007729A (en) 2001-10-30

Family

ID=22894903

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007729-1A BR0007729A (en) 1999-01-26 2000-01-26 Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound

Country Status (20)

Country Link
EP (1) EP1144418A1 (en)
JP (1) JP2002535335A (en)
KR (1) KR20010101649A (en)
CN (1) CN1188417C (en)
AU (1) AU2624600A (en)
BG (1) BG105737A (en)
BR (1) BR0007729A (en)
CA (1) CA2355738A1 (en)
CZ (1) CZ20012691A3 (en)
EA (1) EA200100813A1 (en)
HK (1) HK1038747A1 (en)
HU (1) HUP0200013A3 (en)
ID (1) ID29400A (en)
IL (1) IL144116A0 (en)
NO (1) NO20013640D0 (en)
PL (1) PL349874A1 (en)
SK (1) SK10142001A3 (en)
TR (1) TR200102133T2 (en)
WO (1) WO2000043399A1 (en)
ZA (1) ZA200104323B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2406267B1 (en) * 2009-03-10 2019-02-20 L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Cyclic amino compounds for low-k silylation
CN109422765B (en) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C-class beta-lactamase inhibitor and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
EP0083977A1 (en) * 1982-01-11 1983-07-20 Pfizer Inc. 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US4503040A (en) * 1984-02-27 1985-03-05 Pfizer Inc. 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4591459A (en) * 1984-12-03 1986-05-27 Pfizer Inc. Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors

Also Published As

Publication number Publication date
HK1038747A1 (en) 2002-03-28
BG105737A (en) 2002-05-31
CZ20012691A3 (en) 2002-06-12
TR200102133T2 (en) 2001-12-21
EA200100813A1 (en) 2003-02-27
IL144116A0 (en) 2002-05-23
EP1144418A1 (en) 2001-10-17
AU2624600A (en) 2000-08-07
HUP0200013A2 (en) 2002-05-29
NO20013640L (en) 2001-07-24
HUP0200013A3 (en) 2002-10-28
PL349874A1 (en) 2002-09-23
KR20010101649A (en) 2001-11-14
WO2000043399A1 (en) 2000-07-27
ID29400A (en) 2001-08-30
ZA200104323B (en) 2002-08-26
SK10142001A3 (en) 2002-07-02
JP2002535335A (en) 2002-10-22
CN1337965A (en) 2002-02-27
NO20013640D0 (en) 2001-07-24
CN1188417C (en) 2005-02-09
CA2355738A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
ES2188194T3 (en) 1,8-NAFTIRIDIN-4 (1H) -ONON REPLACED AS INHIBITORS OF PHOSPHODESTERASE 4.
AR011093A1 (en) COMPOUNDS DERIVED FROM SULFONIL UREA, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCEDURE FOR ITS USE.
BG93979A (en) N-(4-PIPERIDINYL)(DIHYDROBENZOFURAN OR DIHYDRO-2H-BENZOPYRAN)CARBOXAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARING THE DERIVATIVES AND THEIR APPLICATION
DE69920509D1 (en) PYRIMIDINE CONNECTIONS
ES8800150A1 (en) 5-substituted-3-aminoalkyl indole derivatives for migraine
ES8606306A1 (en) Benzoxazol- and benzothiazolamine derivatives.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
NO324229B1 (en) 2-hydroxymutiline carbamate derivatives, their use, pharmaceutical composition and process for preparing such a compound
HUP0203184A2 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
DE69431069T2 (en) CYCLIC AMID DERIVATIVES AS NEUROKININ A ANTAGONISTS
IL163625A0 (en) Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
AU591165B2 (en) Angiotensin converting enzyme inhibitors
MX9804052A (en) Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf)
HUP0103316A2 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
DK0628040T3 (en) Indole derivatives as steroid 5alpha reductase inhibitors
BR0007729A (en) Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound
DE59304311D1 (en) N-SUBSTITUTED 3-AZABICYCLO [3.2.0] HEPTANE DERIVATIVES AS A NEUROLEPTIC
NZ220195A (en) 2-pyridyl-penem derivatives and pharmaceutical compositions
HUP0004317A2 (en) 5-ht1f agonists
DE69314649T2 (en) CHINUCLIDINE DERIVATIVES AS SQUAL SYNTHASE INHIBITORS
DK115491A (en) OEPHENYLAA (3-PYRIDINYL) METHANON, OXIMARY DERIVATIVES
ES2001893A6 (en) Methylendioxyphenathrene and stilben derivatives, process for the preparation thereof, pharmaceutical compositions using these, and therapeutic applications
NZ512891A (en) S-oxide lipid lowering compounds
EA200200292A1 (en) HYGROMYCIN DERIVATIVES
IL115085A0 (en) Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.